EKOS
Bothell
About EKOS
EKOS Corporation pioneered the development and the clinical application of ultrasound accelerated thrombolysis, introducing its first system for the treatment of vascular thrombosis in 2005. Today, interventional radiologists, cardiologists and vascular surgeons at leading institutions around the world use the EKOS EkoSonic Endovascular System to provide faster, safer and more complete dissolution of thrombus.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $49.0M
- Funding stage: M&A
- Last round: Series C (Mar 2008)
- Website: ekoscorp.com
- Phone: 4254153102
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/ekos-2415572 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.